These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1558834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
    Savi P, Laplace MC, Maffrand JP, Herbert JM.
    J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
    [Abstract] [Full Text] [Related]

  • 3. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN, Colman RF, Colman RW.
    Eur J Biochem; 1996 Mar 15; 236(3):862-70. PubMed ID: 8665907
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.
    Gachet C, Cattaneo M, Ohlmann P, Hechler B, Lecchi A, Chevalier J, Cassel D, Mannucci PM, Cazenave JP.
    Br J Haematol; 1995 Oct 15; 91(2):434-44. PubMed ID: 8547091
    [Abstract] [Full Text] [Related]

  • 6. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN, Zhou FX, Bradford H, Hu CJ, Colman RF, Colman RW.
    Arch Biochem Biophys; 1989 Jun 15; 271(2):346-58. PubMed ID: 2543293
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
    Defreyn G, Gachet C, Savi P, Driot F, Cazenave JP, Maffrand JP.
    Thromb Haemost; 1991 Feb 12; 65(2):186-90. PubMed ID: 2053105
    [Abstract] [Full Text] [Related]

  • 11. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
    Gachet C, Stierlé A, Cazenave JP, Ohlmann P, Lanza F, Bouloux C, Maffrand JP.
    Biochem Pharmacol; 1990 Jul 15; 40(2):229-38. PubMed ID: 2375765
    [Abstract] [Full Text] [Related]

  • 12. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
    Hechler B, Eckly A, Ohlmann P, Cazenave JP, Gachet C.
    Br J Haematol; 1998 Dec 15; 103(3):858-66. PubMed ID: 9858246
    [Abstract] [Full Text] [Related]

  • 13. Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets.
    Savi P, Artçanuthurry V, Bornia J, Grelac F, Maclouf J, Levy-Toledano S, Herbert JM.
    Br J Haematol; 1997 Apr 15; 97(1):185-91. PubMed ID: 9136964
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of an ADP receptor mediating platelet activation.
    Colman RW, Figures WR.
    Mol Cell Biochem; 1984 Apr 15; 59(1-2):101-11. PubMed ID: 6323960
    [Abstract] [Full Text] [Related]

  • 15. Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel.
    Savi P, Bornia J, Salel V, Delfaud M, Herbert JM.
    Br J Haematol; 1997 Sep 15; 98(4):880-6. PubMed ID: 9326183
    [Abstract] [Full Text] [Related]

  • 16. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A, Asai F, Ogawa T, Inoue T, Koike H.
    Br J Pharmacol; 2000 Apr 15; 129(7):1439-46. PubMed ID: 10742300
    [Abstract] [Full Text] [Related]

  • 17. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
    Gachet C, Cazenave JP, Ohlmann P, Bouloux C, Defreyn G, Driot F, Maffrand JP.
    Biochem Pharmacol; 1990 Dec 15; 40(12):2683-7. PubMed ID: 2175608
    [Abstract] [Full Text] [Related]

  • 18. Evidence for the existence of two different ADP-binding sites on rat platelets.
    Savi P, Laplace MC, Herbert JM.
    Thromb Res; 1994 Oct 15; 76(2):157-69. PubMed ID: 7863466
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
    Puri RN, Colman RW.
    Arch Biochem Biophys; 1991 May 01; 286(2):419-27. PubMed ID: 1910292
    [Abstract] [Full Text] [Related]

  • 20. ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes--an effect selectively blocked by the thienopyridine clopidogrel.
    Gachet C, Savi P, Ohlmann P, Maffrand JP, Jakobs KH, Cazenave JP.
    Thromb Haemost; 1992 Jul 06; 68(1):79-83. PubMed ID: 1514178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.